AD has been argued to be “Type 3 diabetes” [39], since the brains of AD patients and rodent models often display impairments in brain insulin responsiveness, glucose utilization, and energy metabolism [40–45], while treatments aimed to ameliorate these impairments can improve cognitive function [45–52]. Here, INS is linked to Alzheimer disease.